An interview with Elin Haf Davies, CEO and founder of aparito As if the small number of patients is not enough of a hurdle, snapshot and episodic collection methods can make it impossible to amass the data needed to convince regulators and reimbursement agencies that therapies for rare diseases are effective. Wearables can help, says Elin Haf Davies, founder and CEO of aparito.
On the occasion of the first DIA BioVenture day on 28 March 2017 in Glasgow, Menno Aarnout, Wolfgang Stoiber and EBE's Barbara Freischem discussed options for solutions to support the development and funding of Advanced Therapies and Breakthrough Medicines in Europe.
On 6 October 2016, the IMI GetReal project hosted a webinar “Identifying and addressing the operational challenges of pragmatic trials”. The webinar showcased GetReal’s Work Package 3 (WP3), providing guidance on the optimisation and feasibility of pragmatic trials. The webinar also presented PragMagic, a decision support tool being developed by WP3 to help researchers design pragmatic trials.
The Lithuanian Health Forum Conference held in Vilnius, was organised to consolidate and address the policies, goals, and objectives of the Vilnius Declaration’s“Sustainable Health Systems for Inclusive Growth”, which was developed and circulated internationally during the 2013 European Council Presidency.
On 17th June 2016, GetReal held the conference “Putting Real World Healthcare Data to Work” in London. The aim of the conference was to gather perspectives of key stakeholders on the potential value of GetReal in decision-making within industry, regulatory authorities, HTAs, and for patients. Following a series of [...]
Duane Schulthess of Vital Transformation sits down for a one on one discussion with Luca Pani, the Director General of the Italian Medicines Agency, to discuss his new book "Sustainable Innovation: Medicines and the Challenges for the Future of our National Health Service". This 30 minute podcast recording [...]
June 29, 2016, Philadelphia Europe and the US are experimenting with ways to develop therapies based on their actual ‘real world’ performance. This session will discuss the benefits and challenges of outcomes-based health care, as well as the remaining barriers to implementation.
On 10 May 2016, thought leaders involved in the IMI GetReal initiative met in Bern, Switzerland for the webinar “Synthesis and integration of real-world evidence in network meta-analyses and outcome prediction”. The webinar gave participants an understanding of important methodological key deliverables achieved by the IMI GetReal team. [...]
On 18 April 2016, leaders from IMI GetReal met at the Takeda offices in London for a live broadcast: “Introduction to the concept of drivers of effectiveness”. The broadcast introduced the concept of drivers of effectiveness and provided an overview of the methods that can be used to identify them [...]
March 23, 2016
On 23 March 2016, leaders from the IMI GetReal project met in London to for the webinar “Effectiveness research: navigating real world solutions”. Part of the IMI GetReal project has focused on exploring how best to tackle effectiveness research before marketing authorisation. Towards this end, the project has gathered valuable insight from stakeholders and decision-makers on the value of real-world evidence and the acceptability of approaches to gather that evidence to support marketing authorisation and subsequent HTA assessment.